Global Immuno-oncology Therapeutics Market 2018: Adoptive T-cell Therapies Forecast to 2022 – The Next Generation … – PR Newswire (press release)
|
Global Immuno-oncology Therapeutics Market 2018: Adoptive T–cell Therapies Forecast to 2022 – The Next Generation …
PR Newswire (press release) Chimeric antigen receptor (CAR) T-cell therapy will change the way cancer is being treated. In the second half of 2017, the first two drugs in this new class of therapy were approved. Autologous T-cells that have been re-engineered can resist the … |
